Krishna Shevate
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Krishna Shevate has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Kalirajan Rajagopal
Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India
3 shared publications - Kalyani Asgaonkar
Department of Pharmacognosy, Department of Pharmaceutical Chemistry, All India Shri Shivaji Memorial Society’sCollege of Pharmacy, Pune-01, India
3 shared publications - Abhijit Das1 shared publication
Amruta Avalaskar
1 shared publication- Amruta Avalaskar
Department of Pharmacognosy, Department of Pharmaceutical Chemistry, All India Shri Shivaji Memorial Society’sCollege of Pharmacy, Pune-01, India
1 shared publication Apsara Unni
Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, The Nilgiris, Ooty, Tamil Nadu 643001, India
1 shared publication
Latest Publications
- 24 September 2026
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 22, 1-27
Integrated LC-MS and Computer-aided Drug Design Evaluation of Sida cordifolia Herbal Microemulsion Targeting Inflammatory Enzymes through Molecular Docking, MM-GBSA, DFT, and ADMET Profiling
Introduction: Sida cordifolia(SC) L. is traditionally used to treat inflammatory disorders; however, its molecular composition and mechanisms of action remain poorly understood. This study aimed to investigate its bioactive constituents and evaluate their anti-inflammatory potential using integrated computational and experimental approaches. materials and methods: Phytochemical profiling of SC extract was performed using LC–MS. Identified compounds were assessed for pharmacokinetic and toxicity properties via in silico ADME–Tox prediction. Molecular docking was conducted against key inflammatory enzymes, including secretory phospholipase A₂ (sPLA₂), 5-lipoxygenase (5-LOX), and cyclooxygenase-2 (COX-2). An oil-in-water microemulsion was formulated and characterized for physicochemical properties. Anti-inflammatory activity was evaluated using egg albumin denaturation, heat-induced hemolysis, and in vivo rat paw edema assays. results: Thirteen bioactive phytochemicals were identified and structurally characterized. ADME–Tox predictions indicated favorable pharmacokinetic profiles with low toxicity. The microemulsion showed good stability and suitable physicochemical properties. Docking results revealed strong binding affinities of quinazoline alkaloids and prenylated flavonoids with sPLA₂, 5-LOX, and COX-2, suggesting multi-target inhibition. Experimental assays demonstrated significant anti-inflammatory activity. discussion: The findings indicate that Sida cordifolia contains bioactive phytochemicals capable of targeting key inflammatory enzymes (sPLA₂, 5-LOX, and COX-2). Favorable docking interactions and ADME–Tox profiles, along with the stable microemulsion formulation, support enhanced delivery and activity. The significant effects observed in in vitro and in vivo models suggest a multi-target anti-inflammatory mechanism, supporting the plant’s traditional therapeutic use. conclusion: These findings highlight SC as a promising source of multi-target anti-inflammatory agents. The combined computational, in vitro, and in vivo approaches, along with microemulsion-based delivery, support its therapeutic potential.
- 24 September 2026
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 22, 1-27
Integrated LC-MS and Computer-aided Drug Design Evaluation of Sida cordifolia Herbal Microemulsion Targeting Inflammatory Enzymes through Molecular Docking, MM-GBSA, DFT, and ADMET Profiling
Introduction: Sida cordifolia(SC) L. is traditionally used to treat inflammatory disorders; however, its molecular composition and mechanisms of action remain poorly understood. This study aimed to investigate its bioactive constituents and evaluate their anti-inflammatory potential using integrated computational and experimental approaches. materials and methods: Phytochemical profiling of SC extract was performed using LC–MS. Identified compounds were assessed for pharmacokinetic and toxicity properties via in silico ADME–Tox prediction. Molecular docking was conducted against key inflammatory enzymes, including secretory phospholipase A₂ (sPLA₂), 5-lipoxygenase (5-LOX), and cyclooxygenase-2 (COX-2). An oil-in-water microemulsion was formulated and characterized for physicochemical properties. Anti-inflammatory activity was evaluated using egg albumin denaturation, heat-induced hemolysis, and in vivo rat paw edema assays. results: Thirteen bioactive phytochemicals were identified and structurally characterized. ADME–Tox predictions indicated favorable pharmacokinetic profiles with low toxicity. The microemulsion showed good stability and suitable physicochemical properties. Docking results revealed strong binding affinities of quinazoline alkaloids and prenylated flavonoids with sPLA₂, 5-LOX, and COX-2, suggesting multi-target inhibition. Experimental assays demonstrated significant anti-inflammatory activity. discussion: The findings indicate that Sida cordifolia contains bioactive phytochemicals capable of targeting key inflammatory enzymes (sPLA₂, 5-LOX, and COX-2). Favorable docking interactions and ADME–Tox profiles, along with the stable microemulsion formulation, support enhanced delivery and activity. The significant effects observed in in vitro and in vivo models suggest a multi-target anti-inflammatory mechanism, supporting the plant’s traditional therapeutic use. conclusion: These findings highlight SC as a promising source of multi-target anti-inflammatory agents. The combined computational, in vitro, and in vivo approaches, along with microemulsion-based delivery, support its therapeutic potential.
- Open Access
- 7 May 2026
- Published by Journal of Integrative and Translational Biomedicine in Journal of Integrative and Translational Biomedicine
- Vol. 1 (2) , 11-23
Current Status and Mechanisms of Antibiotic Resistance in Microorganisms
Antibiotic resistance has emerged as one of the most critical challenges to global public health, undermining the effectiveness of existing antimicrobial therapies and threatening the management of infectious diseases. Resistance through diverse genetic and molecular mechanisms enables microorganisms to survive sustained antibiotic effect and persist across clinical, community, and environmental settings. This review provides a comprehensive overview of current status and biological mechanisms of antibiotic resistance in microorganisms. We examine the evolutionary origins of resistance, the genetic architecture underlying resistance acquisition and dissemination, and core molecular processes that reduce antibiotic efficacy. Specific attention is given to resistance expression in host environments, including roles of immune system, microbial interactions, phenotypic heterogeneity, and persister cells in treatment failure. The review explores global landscape of antibiotic resistance, including priority pathogens, regional variations, and influence of healthcare systems. Furthermore, advances in resistance detection methods are discussed. These include phenotypic, molecular, and genomic approaches, along with challenges associated with their clinical interpretation. Finally, current strategies to control antibiotic resistance and future directions for research, surveillance, and policy development are highlighted. By integrating evolutionary, molecular, and clinical perspectives, this review identifies key knowledge gaps and emphasizes need for coordinated, biologically informed approaches to mitigate antibiotic resistance and preserve antimicrobial efficacy.
- 7 May 2026
- Published by Journal of Integrative and Translational Biomedicine in Journal of Integrative and Translational Biomedicine
- Vol. 1 (2) , 11-23
Open AccessCurrent Status and Mechanisms of Antibiotic Resistance in Microorganisms
Antibiotic resistance has emerged as one of the most critical challenges to global public health, undermining the effectiveness of existing antimicrobial therapies and threatening the management of infectious diseases. Resistance through diverse genetic and molecular mechanisms enables microorganisms to survive sustained antibiotic effect and persist across clinical, community, and environmental settings. This review provides a comprehensive overview of current status and biological mechanisms of antibiotic resistance in microorganisms. We examine the evolutionary origins of resistance, the genetic architecture underlying resistance acquisition and dissemination, and core molecular processes that reduce antibiotic efficacy. Specific attention is given to resistance expression in host environments, including roles of immune system, microbial interactions, phenotypic heterogeneity, and persister cells in treatment failure. The review explores global landscape of antibiotic resistance, including priority pathogens, regional variations, and influence of healthcare systems. Furthermore, advances in resistance detection methods are discussed. These include phenotypic, molecular, and genomic approaches, along with challenges associated with their clinical interpretation. Finally, current strategies to control antibiotic resistance and future directions for research, surveillance, and policy development are highlighted. By integrating evolutionary, molecular, and clinical perspectives, this review identifies key knowledge gaps and emphasizes need for coordinated, biologically informed approaches to mitigate antibiotic resistance and preserve antimicrobial efficacy.
- Open Access
- 1 January 2026
- Published by KEAI Publishing in Letters in Drug Design & Discovery
- Vol. 23 (1)
Computational study of Fostemsavir reactivity to understand its degradation properties and its intrinsic stability through DFT and MD approach
- 1 January 2026
- Published by KEAI Publishing in Letters in Drug Design & Discovery
- Vol. 23 (1)
Open AccessComputational study of Fostemsavir reactivity to understand its degradation properties and its intrinsic stability through DFT and MD approach
- 5 September 2025
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 120 (Pt 1) , 108671
Targeting TNBC metastasis: In-silico identification of natural origin ROCK inhibitors via virtual screening, ADMET profiling, MM-GBSA, DFT, and molecular dynamics
- 5 September 2025
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 120 (Pt 1) , 108671
Targeting TNBC metastasis: In-silico identification of natural origin ROCK inhibitors via virtual screening, ADMET profiling, MM-GBSA, DFT, and molecular dynamics